+

WO2003105777A3 - Fiber cell globulization aminopeptidases and methods for treating or preventing cataracts - Google Patents

Fiber cell globulization aminopeptidases and methods for treating or preventing cataracts Download PDF

Info

Publication number
WO2003105777A3
WO2003105777A3 PCT/US2003/019066 US0319066W WO03105777A3 WO 2003105777 A3 WO2003105777 A3 WO 2003105777A3 US 0319066 W US0319066 W US 0319066W WO 03105777 A3 WO03105777 A3 WO 03105777A3
Authority
WO
WIPO (PCT)
Prior art keywords
globulization
methods
fiber cell
aminopeptidases
treating
Prior art date
Application number
PCT/US2003/019066
Other languages
French (fr)
Other versions
WO2003105777A2 (en
Inventor
Satish K Srivastava
Original Assignee
Univ Texas
Satish K Srivastava
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Satish K Srivastava filed Critical Univ Texas
Priority to AU2003243618A priority Critical patent/AU2003243618A1/en
Publication of WO2003105777A2 publication Critical patent/WO2003105777A2/en
Publication of WO2003105777A3 publication Critical patent/WO2003105777A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/553Renin inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed are methods for treating or preventing cataract in a subject by administering to the subject an inhibitor of a fiber cell globulization aminopeptidase or by otherwise inhibiting fiber cell globulization aminopeptidase activity. Methods for inhibiting globulization of fiber cells and for inhibiting opacification of an ocular lens are also disclosed, as are methods for screening test compounds for their usefulness in inhibiting globulization of fiber cells, for their usefulness in inhibiting opacification of an ocular lens, and for their usefulness in treating or preventing cataract. An isolated fiber cell globulization aminopeptidase is also described, as are methods for making such isolated fiber cell globulization aminopeptidases, and antibodies specific for such isolated fiber cell globulization aminopeptidases.
PCT/US2003/019066 2002-06-14 2003-06-14 Fiber cell globulization aminopeptidases and methods for treating or preventing cataracts WO2003105777A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003243618A AU2003243618A1 (en) 2002-06-14 2003-06-14 Fiber cell globulization aminopeptidases and methods for treating or preventing cataracts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38902102P 2002-06-14 2002-06-14
US60/389,021 2002-06-14

Publications (2)

Publication Number Publication Date
WO2003105777A2 WO2003105777A2 (en) 2003-12-24
WO2003105777A3 true WO2003105777A3 (en) 2004-02-26

Family

ID=29736577

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/019066 WO2003105777A2 (en) 2002-06-14 2003-06-14 Fiber cell globulization aminopeptidases and methods for treating or preventing cataracts

Country Status (2)

Country Link
AU (1) AU2003243618A1 (en)
WO (1) WO2003105777A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362324B1 (en) * 1999-06-30 2002-03-26 Millennium Pharmaceuticals, Inc. 17867 a novel human aminopeptidase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362324B1 (en) * 1999-06-30 2002-03-26 Millennium Pharmaceuticals, Inc. 17867 a novel human aminopeptidase

Also Published As

Publication number Publication date
AU2003243618A1 (en) 2003-12-31
WO2003105777A2 (en) 2003-12-24
AU2003243618A8 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
EA200601995A1 (en) PDX1 EXPRESSIVE ENTODERM
ATE262859T1 (en) MULTIFOCAL PHAKIC INTRAOCULAR LENS
EA200300803A1 (en) DERIVATIVES OF XANTHINE, THEIR PRODUCTION AND THEIR APPLICATION AS A MEDICINE
WO2003105725A3 (en) Artificial cornea
EA200501009A1 (en) SUBSTITUTED PYRROPYRAZOLE DERIVATIVES AS KINASE INHIBITORS
EA200601231A1 (en) DEFINITIVE ENTODERMA
AU2006304392A8 (en) Conditionally immortalized long-term stem cells and methods of making and using such cells
DE602004022982D1 (en) USE OF TREPROSTINIL TO IMPROVE THE KIDNEY FUNCTION
EP1563300A4 (en) METHOD FOR DIAGNOSING CELIAC DISEASE
ATE303366T1 (en) 4-AMINO-5-CYANO-2-ANILINO-PYRIMIDINE DERIVATIVES FOR USE AS INHIBITORS OF CELL CYCLE KINASES
ATE342700T1 (en) TWO-PIECE ßLß-SHAPED PHAKIC INTRAOCULAR LENS
EA200300118A1 (en) TETRAHYDROPYRIDINO- OR PIPERIDINO-HETEROCYCLIC DERIVATIVES
EA200800879A1 (en) PPAR GAMMA AGONISTS TO IMPROVE COGNITIVE FUNCTION IN APOE4 NEGATIVE PATIENTS
FR2876582B1 (en) USE OF PYRROLO-PYRAZINE DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF MUCOVISCIDOSIS AND DISEASES ASSOCIATED WITH A DEFECT OF ADDRESSING PROTEINS IN CELLS
ATE221661T1 (en) CELL COUNTING BY AN IMMUNOASSAY
BR0115121A (en) N - ((1,2,4) triazoloazinyl) thiophenesulfonamide compounds as herbicides
WO2003105777A3 (en) Fiber cell globulization aminopeptidases and methods for treating or preventing cataracts
AU2003291134A1 (en) Use of diamide derivatives for inhibiting chronic tissue transplant rejection
WO2005033275A3 (en) Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
NO20060561L (en) Compositions containing sertolic cells and myoid cells and their use in cell grafts
HK1118214A1 (en) A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
MXPA04004018A (en) Methods of screening for toxicity of test compounds.
DE602005027129D1 (en) ISCH AND BIOMATRIX AND METHOD OF MANUFACTURING THEREOF
TR200100475T2 (en) Production and uses of N-substituted azabicycloheptane derivatives.
FR2840446B1 (en) PROCESS FOR RETIREMENT OF AN EXTENDED NUCLEAR FUEL

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载